About this trial
This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).
Eligibility criteria
Qualifiers
None
Disqualifiers
Pregnant women
Women ≤6 weeks postpartum
Women already confirmed to have cervical cancer
Trial design
Treatments tested in this trial
- DADA LINK
Treatment groups
Sponsors and collaborators
Kenyatta National Hospital
Lead sponsor
Emory University
Collaborator
University of Washington
Collaborator
National Cancer Institute (NCI)
Collaborator
Kenya Ministry of Health
Collaborator
Queen's University
Collaborator
University of Nairobi
Collaborator